20/20 BIOLABS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $4.1M |
| FY2024 | $2.1M | $3.6M | $1.8M |
| FY2025 | $4.2M | $4.1M | $1.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $4.1M |
| FY2024 | $2.1M | $3.6M | $1.8M |
| FY2025 | $4.2M | $4.1M | $1.0M |